The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL)...

por Yang, Hua, Huang, Sai, Zhu, Cheng-Ying, Gao, Li, Zhu, Hai-Yan, Lv, Na, Jing, Yu, Yu, Li
Publicado 2016

Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience

por Zhu, Cheng-ying, Zhao, Sha-sha, Wang, Xiao-kai, Wang, Li, Wang, Fei-yan, Fang, Shu, Liu, Zhan-xiang, Guan, Li-xun, Liu, Yu-chen, Ding, Yi, Dou, Li-ping, Wang, Li-li, Gao, Chun-ji
Publicado 2019

Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway

por Wang, Hao, Liu, Yu-chen, Zhu, Cheng-ying, Yan, Fei, Wang, Meng-zhen, Chen, Xiao-su, Wang, Xiao-kai, Pang, Bao-xu, Li, Yong-hui, Liu, Dai-hong, Gao, Chun-ji, Liu, Shu-jun, Dou, Li-ping
Publicado 2020

Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

por Zhu, Cheng-ying, Chen, Guo-feng, Zhou, Wei, Hou, Cheng, Wang, Xiao-kai, Wang, Fei-yan, Yang, Nan, Wang, Li, Fang, Shu, Luo, Lan, Guan, Li-xun, Zhang, Ran, Liu, Yu-chen, Dou, Li-ping, Gao, Chun-ji
Publicado 2019